Caipeng Qin

509 total citations
41 papers, 359 citations indexed

About

Caipeng Qin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Caipeng Qin has authored 41 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Caipeng Qin's work include Bladder and Urothelial Cancer Treatments (15 papers), Ferroptosis and cancer prognosis (8 papers) and Renal cell carcinoma treatment (7 papers). Caipeng Qin is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Ferroptosis and cancer prognosis (8 papers) and Renal cell carcinoma treatment (7 papers). Caipeng Qin collaborates with scholars based in China, United States and Denmark. Caipeng Qin's co-authors include Yiqing Du, Zhengzuo Sheng, Tao Xu, Tao Xu, Yeqing Yuan, Zhenhua Liu, Xiaofeng Wang, Qiang Wang, Xiaowei Zhang and Jing Li and has published in prestigious journals such as Life Sciences, Medicine and Journal of Clinical Pathology.

In The Last Decade

Caipeng Qin

36 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caipeng Qin China 12 202 95 93 85 79 41 359
Xiangshan Yang China 12 133 0.7× 72 0.8× 70 0.8× 76 0.9× 42 0.5× 21 295
Xiuling Wu China 13 196 1.0× 125 1.3× 100 1.1× 61 0.7× 47 0.6× 31 347
Louqian Zhang China 11 149 0.7× 53 0.6× 139 1.5× 147 1.7× 106 1.3× 23 406
Maria Mihaela Mina Italy 8 184 0.9× 113 1.2× 155 1.7× 168 2.0× 66 0.8× 13 363
Renba Liang China 10 212 1.0× 150 1.6× 53 0.6× 145 1.7× 57 0.7× 14 400
Shengming Jin China 13 290 1.4× 210 2.2× 165 1.8× 74 0.9× 44 0.6× 32 481
Feiteng Lu China 12 118 0.6× 77 0.8× 57 0.6× 102 1.2× 63 0.8× 21 306
Kaikai Zhao China 10 222 1.1× 146 1.5× 173 1.9× 108 1.3× 67 0.8× 27 420
Alessandra Modena Italy 11 148 0.7× 114 1.2× 183 2.0× 147 1.7× 42 0.5× 29 368
Honggang Ke China 13 177 0.9× 151 1.6× 164 1.8× 100 1.2× 35 0.4× 24 369

Countries citing papers authored by Caipeng Qin

Since Specialization
Citations

This map shows the geographic impact of Caipeng Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caipeng Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caipeng Qin more than expected).

Fields of papers citing papers by Caipeng Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caipeng Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caipeng Qin. The network helps show where Caipeng Qin may publish in the future.

Co-authorship network of co-authors of Caipeng Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Caipeng Qin. A scholar is included among the top collaborators of Caipeng Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caipeng Qin. Caipeng Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Guiting, et al.. (2025). Amniotic fluid stem cell therapy improves erectile function in a diabetic rat model. Andrology. 14(2). 603–610.
2.
Peng, Yun, Caipeng Qin, Mengting Ding, et al.. (2025). Genomic subtypes of non-muscle-invasive bladder cancer: guiding immunotherapy decision-making for patients exposed to aristolochic acid. Molecular Medicine. 31(1). 140–140. 1 indexed citations
3.
4.
Song, Yuxuan, Yun Peng, Jiaxing Lin, et al.. (2024). The role of histological subtype and chemotherapy on prognosis of ureteral cancer. Journal of Cancer Research and Clinical Oncology. 150(4). 192–192. 2 indexed citations
5.
Song, Yuxuan, Caipeng Qin, Yun Peng, et al.. (2023). GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females. Journal of Cancer Research and Clinical Oncology. 149(10). 6827–6840. 2 indexed citations
6.
7.
Song, Yuxuan, Yun Peng, Caipeng Qin, et al.. (2023). Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment. Journal for ImmunoTherapy of Cancer. 11(9). e006643–e006643. 17 indexed citations
8.
Lin, Jiaxing, Mengting Ding, Caipeng Qin, et al.. (2023). A robust gene prognostic index composed of GZMB, IRF1, and TP63 can stratify the risk of two metastatic urothelial carcinoma cohorts based on immune checkpoint blockade therapy. Journal of Cancer Research and Clinical Oncology. 149(12). 9877–9890.
9.
10.
Wang, Fei, Yiqing Du, Caipeng Qin, et al.. (2022). Could Metabolic Syndrome Be a Predictor of Survival Outcomes in Upper Tract Urothelial Carcinoma? A Propensity Score Matching Study in a Large Chinese Center. Frontiers in Oncology. 12. 816915–816915. 1 indexed citations
11.
Qin, Caipeng, Jing Wang, Yiqing Du, & Tao Xu. (2022). Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer. Frontiers in Endocrinology. 13. 1055826–1055826. 9 indexed citations
12.
Song, Yuxuan, Yiqing Du, Caipeng Qin, et al.. (2022). Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment. Frontiers in Cell and Developmental Biology. 9. 809620–809620. 12 indexed citations
13.
Yang, Wenbo, et al.. (2022). Intratumoral fibrosis and patterns of immune infiltration in clear cell renal cell carcinoma. BMC Cancer. 22(1). 661–661. 4 indexed citations
14.
Du, Yiqing, Wenbo Yang, Huixin Liu, et al.. (2021). Perirenal Fat as a New Independent Prognostic Factor in Patients With Surgically Treated Clear Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer. 20(1). e75–e80. 11 indexed citations
15.
Qin, Caipeng, et al.. (2021). Siglec-15 promotes progression of clear renal cell carcinoma. Chinese Medical Journal. 134(21). 2635–2637. 7 indexed citations
16.
Qin, Caipeng, Qiang Wang, Xiaowei Zhang, et al.. (2019). Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects. Molecular Cancer Therapeutics. 18(12). 2433–2445. 14 indexed citations
17.
Liu, Huixin, Qing Li, Xiaowei Zhang, et al.. (2017). Development and Initial Validation of the Novel Scale for Assessing Quality of Life of Prostate Cancer Patients Receiving Androgen Deprivation Therapy. Chinese Medical Journal. 130(17). 2082–2087. 1 indexed citations
18.
Sheng, Zhengzuo, Xiaowei Zhang, Yiqing Du, et al.. (2016). Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7. Oncology Reports. 37(2). 1045–1051. 32 indexed citations
19.
Qin, Caipeng, Zhenhua Liu, Yeqing Yuan, et al.. (2014). Glycoprotein non-metastatic melanoma protein B as a predictive prognostic factor in clear-cell renal cell carcinoma following radical nephrectomy. Molecular Medicine Reports. 9(3). 851–856. 10 indexed citations
20.
Liu, Zhenhua, Jing Xie, Yunbei Xiao, et al.. (2013). [Free fatty acids induce proliferation of human renal carcinoma 786-O cell line via integrin-linked kinase].. PubMed. 45(2). 217–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangshan Yang Breakdown of academic impact, for papers by Xiuling Wu Breakdown of academic impact, for papers by Louqian Zhang Breakdown of academic impact, for papers by Maria Mihaela Mina Breakdown of academic impact, for papers by Renba Liang Breakdown of academic impact, for papers by Shengming Jin Breakdown of academic impact, for papers by Feiteng Lu Breakdown of academic impact, for papers by Kaikai Zhao Breakdown of academic impact, for papers by Alessandra Modena Breakdown of academic impact, for papers by Honggang Ke
Rankless by CCL
2026